$CLNN
Clene Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Clene Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $3.18 at 03:22 PM on Nov 17, then ran to $3.78 +19% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is CLNN up today? It is at $3.59 (+0.57%), and our scanner flagged it 24 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CLNN spikes, and full due diligence on CLNN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CLNN 24 times in the last 30 days. Create a free account to track $CLNN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how CLNN traded in the last session, Friday (last price and move above). Our scanner fired 6 unusual-volume and momentum alerts on CLNN on Friday, peaking at 15.9x its normal volume.
Likely catalystClene Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 19, 2026 · 2 days agoAcross every filing on file, supply equal to 11.6% of the tradeable float is in play - 11.6% more can still be issued.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
1,219,513 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $160.0M in size · Priced at $3.28/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Wilcox Reed N Director | Bought (open market) | +10K 0.07% of company | added 35% | 39K | $34K at $3.42 | Nov 18, 26 |
Mosca Alison Director | Acquired (grant/award) | +198K 1.4% of company | added 39% | 702K | $650K at $3.28 | Sep 16, 26 |
Etherington Robert Dee Officer | Acquired (grant/award) | +15K 0.1% of company | added 38% | 55K | $50K at $3.28 | Sep 16, 26 |
Matlin David J Director | Acquired (grant/award) | +434K 3.0% of company | added 91% | 912K | $1.4M at $3.28 | Sep 16, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -73K 0.5% of company | sold 41% | 103K | $454K at $6.20 | May 12, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -22K 0.2% of company | sold 11% | 177K | $150K at $6.75 | May 11, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -73K 0.5% of company | sold 27% | 199K | $496K at $6.80 | May 4, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -6K 0.04% of company | sold 2.1% | 272K | $35K at $6.01 | May 1, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -6K 0.04% of company | sold 2.0% | 278K | $35K at $6.08 | Apr 30, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -12K 0.08% of company | sold 4.1% | 283K | $69K at $5.63 | Apr 29, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -2K 0.01% of company | sold 0.5% | 295K | $9K at $5.90 | Apr 28, 26 |
Ugwumba Chidozie Beneficial Owner (10%) | Sold (automatic/other) | -61K 0.4% of company | sold 17% | 297K | $377K at $6.14 | Apr 21, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how CLNN traded in the last session, Friday (last price and move above). Our scanner fired 6 unusual-volume and momentum alerts on CLNN on Friday, peaking at 15.9x its normal volume.
CLNN last traded at $3.59, up 0.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CLNN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLNN 24 times in the last 30 days.
CLNN (Clene Inc. Common Stock) trades on XNAS, with a market cap of about $51M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLNN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CLNN discussion
Sign in to ask a question or join the discussion.